Copyright
©The Author(s) 2021.
World J Gastroenterol. Jul 14, 2021; 27(26): 4208-4220
Published online Jul 14, 2021. doi: 10.3748/wjg.v27.i26.4208
Published online Jul 14, 2021. doi: 10.3748/wjg.v27.i26.4208
Figure 3 Comparison of the cytotoxicities of norcantharidin (NCTD), NCTD-loaded metal-organic framework IRMOF-3, and NCTD-loaded metal-organic framework IRMOF-3 coated with temperature-sensitive gel.
The inhibitory effect of norcantharidin (NCTD)-loaded metal-organic framework IRMOF-3 coated with temperature-sensitive gel (NCTD-IRMOF-3-Gel) (C) on Hepa1-6 cells was stronger than that of NCTD (A) and NCTD-loaded metal-organic framework IRMOF-3 (NCTD-IRMOF-3) (B) and showed a certain sustained-release effect.
- Citation: Li XY, Guan QX, Shang YZ, Wang YH, Lv SW, Yang ZX, Wang R, Feng YF, Li WN, Li YJ. Metal-organic framework IRMOFs coated with a temperature-sensitive gel delivering norcantharidin to treat liver cancer. World J Gastroenterol 2021; 27(26): 4208-4220
- URL: https://www.wjgnet.com/1007-9327/full/v27/i26/4208.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i26.4208